Host-cell survival and death during Chlamydia infection

Current Immunology Reviews

Volumn 3, Issue 1, 2007, Pages 31-40

  Ying, Songmin ^a   Pettengill, Matthew ^b   Ojcius, David M ^b   Häcker, Georg ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Apoptosis; Chlamydia; Danger signals; Inflammation; Necrosis

Indexed keywords

APOPTOTIC PROTEASE ACTIVATING FACTOR 1; BH3 PROTEIN; BIM PROTEIN; CASPASE 3; CASPASE 8; CASPASE 9; CYTOCHROME C; DEATH RECEPTOR; FAS ANTIGEN; FAS LIGAND; FLICE INHIBITORY PROTEIN; HIGH MOBILITY GROUP B1 PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INHIBITOR OF APOPTOSIS PROTEIN 1; INHIBITOR OF APOPTOSIS PROTEIN 2; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN BAD; PROTEIN BAK; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL W; PROTEIN BCL XL; PROTEIN BID; PROTEIN KINASE B; PROTEIN KINASE C DELTA; TOLL LIKE RECEPTOR; TRANSCRIPTION FACTOR RELA;

ADAPTIVE IMMUNITY; ANTIGEN PRESENTING CELL; APOPTOSIS; BACTERIAL IMMUNITY; BACTERIAL TRANSMISSION; BLINDNESS; CELL DEATH; CELL SURVIVAL; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; CHLAMYDOPHILA PNEUMONIAE; CYTOTOXIC T LYMPHOCYTE; DISEASE PREDISPOSITION; ENZYME ACTIVATION; ENZYME RELEASE; GENE DELETION; HOST CELL; HOST PATHOGEN INTERACTION; HUMAN; IMMUNOPATHOGENESIS; INFLAMMATION; INNATE IMMUNITY; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; REVIEW; SEXUALLY TRANSMITTED DISEASE;

EID: 34247218700     PISSN: 15733955     EISSN: None     Source Type: Journal    
DOI: 10.2174/157339507779802179     Document Type: Review

References (158)

1. Miller WC, Ford CA, Morris M et al. Prevalence of chlamydial and gonococcal infections among young adults in the United States. JAMA 2004; 291: 2229-2236.
2. Burstein GR, Gaydos CA, Diener-West M, Howell MR, Zenilman JM, Quinn TC. Incident Chlamydia trachomatis infections among inner-city adolescent females. JAMA 1998; 280: 521-526.
3. Cohen DA, Nsuami M, Etame RB, et al. A school-based Chlamydia control program using DNA amplification technology. Pediatrics 1998; 101: e1.
4. Thylefors B, Negrel AD, Pararajasegaram R, Dadzie KY. Global data on blindness. Bull World Health Organ 1995; 73: 115-121.
5. Campbell LA, Kuo CC. Chlamydia pneumoniae - an infectious risk factor for atherosclerosis? Nature Rev Microbiol 2004; 2: 23-32.
6. Moulder JW. Interaction of chlamydiae and host cells in vitro. Microbiol Rev 1991; 55: 143-190.
7. Wyrick PB. Intracellular survival by Chlamydia. Cell Microbiol 2000; 2: 275-282.
8. Bavoil PM, Hsia R-c, Ojcius DM. Closing in on Chlamydia and its intracellular bag of tricks. Microbiol 2000; 146: 2723-2731.
9. Clifton DR, Fields KA, Grieshaber SS, et al. A chlamydial type III translocated protein is tyrosine-phosphorylated at the site of entry and associated with recruitment of actin. Proc Natl Acad Sci USA 2004; 101: 10166-10171.
10. Stephens RS, Kalman S, Lammel C, et al. Genome sequence of an obligate intracellular pathogen of humans: Chlamydia trachomatis. Science 1998; 23: 638-639.
11. Hsia R-c, Pannekoek Y, Ingerowski E, Bavoil PM. Type III secretion genes identify a putative virulence locus of Chlamydia. Mol Microbiol 1997; 5:351-359.
12. Bavoil PM, Hsia R-c, Rank RG. Prospects for a vaccine against Chlamydia genital disease. I. Microbiology and pathogenesis. Bull Inst Pasteur 1996; 94: 5-54.
13. Ward ME. Mechanisms of Chlamydia-induced disease. In: Stephens RS, editor. Chlamydia: intracellular biology, pathogenesis, and immunity. Washington, D.C.: ASM Press; 1999. p. 171-210.
14. Darville T, Andrews CW, Laffoon KK, Shymasani W, Kishen LR, Rank RG. Mouse strain-dependent variation in die course and outcome of chlamydial genital infection is associated with differences in host response. Infect Immun 1997; 65: 3064-3073.
15. Medzhitov R, Janeway Jr. CA. Decoding the patterns of self and nonself by the innate immune system Science 2002; 296: 298-300.
16. Akira S, Takeda K, Kaisho T. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol 2001; 2: 675-680.
17. O'Neill LA. Immunity's early-warning system. Sci Am J 2005; 292: 38-45.
18. Heine H, Muller-Loennis S, Brade L, Lindner B, Brade H. Endotoxic activity and chemical structure of lipopolysaccharides from Chlamydia trachomatis serotypes E and L2 and Chlamydophila psittaci 6BC. Eur J Biochem 2003; 270: 440-450.
19. Bulut Y, Faure E, Thomas L, et al. Chlamydial heat shock protein 60 activates macrophages and endothelial cells through Toll-like receptor 4 and MD2 in a MyD88-dependent pathway. J Immunol 2002; 168:1435-1440.
20. Ohashi K, Burkart V, Flohe S, Kolb H. Heat shock protein 60 is a putative endogenous ligand of the toll-like receptor-4 complex. J Immunol 2000; 164: 558.
21. Kol A, Lichtman AH, Finberg RW, Libby P, Kurt-Jones EA. Cutting edge: heat shock protein (HSP) 60 activates the innate immune response: CD14 is an essential receptor for HSP60 activation of mononuclear cells. J Immunol 2000; 164: 13-17.
22. Da Costa CU, Wantia N, Kirschning CJ, et al. Heat shock protein 60 from Chlamydia pneumoniae elicits an unusual set of inflammatory responses via Toll-like receptor 2 and 4 in vivo. Eur J Immunol 2004; 34:2874-2884.
23. Erridge C, Pridmore A, Eley A, Stewart J, Poxton IR. Lipopolysaccharides of Bacteroides fragilis, Chlamydia trachomatis and Pseudomonas aeruginosa signal via toll-like receptor 2. J Med Microbiol 2004; 53: 735-740.
24. Costa CP, Kirschning CJ, Busch D, et al. Role of chlamydial heat shock protein 60 in the stimulation of innate immune cells by Chlamydia pneumoniae. Eur J Immunol 2002; 32:2460-2470.
25. Prebeck S, Kirschning C, Durr S, et al. Predominant role of Toll-like receptor 2 versus 4 in Chlamydia pneumoniae-induced activation of dendritic cells. J Immunol 2001; 167: 3316-3323.
26. Darville T, O'Neill JM, Andrews Jr CW, Nagarajan UM, Stahl L, Ojcius DM. Toll-like receptor-2, but not Toll-like receptor-4, is essential for development of oviduct pathology in chlamydial genital tract infection. J Immunol 2003; 171: 6187-6197.
27. Cohen CR, Brunham RC. Pathogenesis of Chlamydia induced pelvic inflammatory disease. Sex Trans Infect 1999; 75: 21-24.
28. Vaux DL, Hacker G, Strasser A. An evolutionary perspective on apoptosis. Cell 1994; 76: 777-779.
29. Jäättelä M, Tschopp J. Caspase-independent cell death in T lymphocytes. Nat Immunol. 2003; 4: 416-423.
30. Leist M, Jäättelä M. Four deaths and a funeral: from caspases to alternative mechanisms. Nat Rev Mol Coll Biol 2001; 2:589-598.
31. Vercammen D, Beyaert R, Denecker G, et al. Inhibition of caspases increases the sensitivity of L929 cells to necrosis mediated by tumor necrosis factor. J Exp Med 1998; 187: 1477-1485.
32. Wyllie AH. Apoptosis: an overview. Br Med Bull 1997; 53: 451-465.
33. Golstein P, Ojcius DM, Young JD. Cell death mechanisms and the immune system. Immunol Rev 1991; 121: 29-65.
34. Hengartner MO. The biochemistry of apoptosis. Nature 2000; 407: 770-776.
35. Krammer PH. CD95's deadly mission in the immune system. Nature 2000; 407: 789-795.
36. Green DR, Reed JC. Mitochondria and apoptosis. Science 1998; 281: 1309-1312.
37. Salvesen GS, Duckett CS. Apoptosis: IAP proteins: blocking the road to death's door. Nat Rev Mol Cell Biol 2002; 3: 401-410.
38. Cohen GM. Caspases: the executioners of apoptosis. Biochem J 1997; 326:1-16.
39. Chipuk JE, Green DR. Do inducers of apoptosis trigger caspase-independent cell death? Nat Rev Mol Cell Biol 2005; 6: 268-275.
40. Lieberman J. The ABCs of granule-mediated cytotoxicity: new weapons in the arsenal. Nat Rev Immunol 2003; 3: 361-370.
41. Ekert PG, Vaux DL. The mitochondrial death squad: hardened killers or innocent bystanders? Curr Opin Cell Biol 2005; 17: 626-630.
42. Barnhart BC, Alappat EC, Peter ME. The CD95 type I/type II model. Semin Immunol 2003; 15:185-193.
43. Willis SN, Adams JM. Life in the balance: how BH3-only proteins induce apoptosis. Curr Opin Cell Biol 2005; 17: 617-625.
44. Bouillet P, Metcalf D, Huang DC, et al. Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity. Science 1999; 286: 1735-1738.
45. Bauer A, Villunger A, Labi V, et al. The NF-kappaB regulator Bcl-3 and the BH3-only proteins Bim and Puma control the death of activated T cells. Proc Natl Acad Sci USA 2006; 103: 10979-10984.
46. Villunger A, Michalak EM, Coultas L, et al. p53- and drug-induced apoptatic responses mediated by BH3-only Proteins puma and noxa. Science 2003; 302: 1036-1038.
47. Puthalakath H, Huang DC, O'Reilly LA. King SM, Strasser A. The proapoptotic activity of the Bcl-2 family member Bim is regulated by interaction with the dynein motor complex. Mol Cell 1999; 3: 287-296.
48. Puthalakath H, Villunger A, O'Reilly LA, et al. Bmf: a proapoptotic BH3-only protein regulated by interaction with the myosin V actin motor complex, activated by anoikis. Science 2001; 293: 1829-1832.
49. Zhu Y, Swanson BJ, Wang M, et al. Constitutive association of the proapoptotic protein Bim with Bcl-2-related proteins on mitachondria in T cells. Proc Natl Acad Sci USA 2004; 101: 7681-7686.
50. Gomez-Bougie P, Bataille R, Amiot M. Endogenous association of Bim BH3-only protein with Mcl-1, Bcl-xL and Bcl-2 on mitochondria in human B cells. Eur J Immunol 2005; 35: 971-976.
51. Zha J, Harada H, Yang E, Jockel J, Korsmeyer SJ. Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-X(L). Cell 1996; 87: 619-628.
52. Li H, Zhu H, Xu CJ, Yuan J. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 1998; 94(4):491-501.
53. Luo X, Budihardjo I, Zou H, Slaughter C, Wang X. Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell 1998; 94(4):481-90.
54. Han J, Flemington C, Houghton AB, et al. Expression of bbc3, a pro-apoptotic BH3-only gene, is regulated by diverse cell death and survival signals. Proc Natl Acad Sci USA 2001; 98(20):11318-23.
55. Nakano K, Vousden KH. PUMA, a novel proapoptotic gene, is induced by p53. Mol Cell 2001; 7(3): 683-94.
56. Oda E, Ohki R, Murasawa H, et al. Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis. Science 2000; 288(5468): 1053-1058.
57. Labi V, Erlacher M, Kiessling S, Villunger A. BH3-only proteins in cell death initiation, malignant disease and anticancer therapy. Cell Death Differ 2006; 13(8):1325-38.
58. Fadok V, Bratton DL, Rose DM, Pearson A, Ezekewitz RAB, Henson PM. A receptor for phosphatidylserine-specific clearance of apoptotic cells. Nature 2000; 405: 85-90.
59. Savill J, Fadok V. Corpse clearance defines the meaning of cell death. Nature 2000; 407: 784-788.
60. Savill J, Dransfield I, Gregory C, Haslett C. A blast from the past: clearance of apoptotic cells regulates immune responses. Nat Rev Immunol 2002; 2: 965-975.
61. Gallucci S, Matzinger P. Danger signals: SOS to the immune system. Curr Opin Immunol 2001; 13:114-119.
62. Matzinger P. The danger model: a renewed sense of self. Science 2002; 296: 301-305.
63. Takeda K, Kaisho T, Akira S. Toll-like receptors. Annu Rev Immunol 2003; 21: 335-376.
64. Di Virgilio F, Chiozzi P, Ferrari D, et al. Nucleotide receptors: an emerging family of regulatory molecules in blood cells. Blood 2001; 97: 587-600.
65. Müller S, Scaffidi P, Degryse B, et al. The double life of HMGB1 chromatin protein: architectural factor and extracellular signal. EMBO J 2001; 16:4337-4340.
66. Sitkovsky MV, Ohta A. The "danger" sensors that STOP the immune response: the A2 adenosine receptors? Trends Immunol 2005; 26: 299-304.
67. Shi Y, Evans JE, Rock KL. Molecular identification of a danger signal that alerts the immune system to dying cells. Nature 2003; 425: 516-521.
68. Stephens RS. The cellular paradigm of chlamydial pathogenesis. Trends Microbiol 2003; 11: 44-51.
69. LaVerda D, Kalayoglu MV, Byrne GI. Chlamydial beat shock proteins and disease pathology: new paradigms for old problems? Infect Dis Obstet Gynecol 1999; 7: 64-71.
70. Fischer SF, Hacker G. Characterization of antiapoptotic activities of Chlamydia pneumoniae in infected cells. Ann N Y Acad Sci 2003; 1010: 565-567.
71. Byrne GI, Ojcius DM.Chlamydia and apoptosis: life and death decisions of an intracellular pathogen. Nat Rev Microbiol 2004; 2: 802-808.
72. Fields KA, Hackstadt T. The chlamydial inclusion: escape from the endocytic pathway. Annu Rev Coll Dev Biol 2002; 18: 221-245.
73. Galvan V, Roizman B. Herpes simplex virus 1 induces and blocks apoptosis at multiple steps during infection and protects cells from exogenous inducers in a cell-type-dependent manner. Proc Natl Acad Sci USA 1998; 95: 3931-3936.
74. Fischer SF, Ludwig H, Holzapfel J, et al. Modified vaccinia virus Ankara protein F1L is a novel BH3-domain-binding protein and acts together with the early viral protein E3L to block virus-associated apoptosis. Cell Death Differ 2006; 13(1): 109-18.
75. Postigo A, Cross JR, Downward J, Way M. Interaction of F1L with the BH3 domain of Bak is responsible for inhibiting vaccinia-induced apoptosis. Cell Death Differ 2006; in press.
76. Wasilenko ST, Banadyga L, Bond D, Barry M. The vaccinia virus F1L protein interacts with the proapoptotic protein Bak and inhibits Bak activation. J Virol 2005; 79: 14031-14043.
77. Miyairi I, Byrne GI. Chlamydia and programmed cell death. Curr Opin Microbiol 2006; 9: 102-108.
78. Verbecke P, Welter-Stahl L, Ying S, et al. Recruitment of BAD by the Chlamydia trachomatis vacuole correlates with host-cell survival. PLoS Pathogens 2006; 2: e45.
79. Ying S, Fischer S, Pettengill M, et al. Characterization of host cell death induced by Chlamydia trachomatis. Infect Immun 2006; 74: 6057-6066.
80. Fan T, Lu H, Shi L, et al. Inhibition of apoptosis in Chlamydia]- infected cells: blockade of mitochondrial cytochrome c release and caspase activation. J Exp Med 1998; 187: 487-496.
81. Fischer SF, Schwarz C, Vier J, Hacker G. Characterization of antiapoptotic activities of Chlamydia pneumoniae in human cells. Infect Immun 2001; 69: 7121-7129.
82. Rajalingam K, Al-Younes H, Muller A, Meyer TF, Szczepek AJ, Rudel T. Epithelial cells inflected with Chlamydophila pneumoniae (Chlamydia pneumoniae) are resistant to apoptosis. Infect Immun 2001; 69: 7880-7888.
83. Fischer SF, Harlander T, Vier J, Hacker G. Protection against CD95-induced apoptosis by chlamydial infection at a mitochondrial step. Infect Immun 204; 72: 1107-1115.
84. Fischer SF, Vier J, Kirschnek S, et al. Chlamydia inhibit host cell apoptosis by degradation of proapoptotic BH3-only proteins. J Exp Med 2004; 200: 905-916.
85. Jungas T, Verbeke P, Darville T, Ojcius DM. Coll death, BAX activation, and HMGB1 release during infection with Chlamydia. Microbes Infect 2004; 6: 1145-1155.
86. Xiao Y, Zhong Y, Greene W, Dong F, Zhong G. Chlamydia trachomatis infection inhibits both Bax and Bak activation induced by staurosporine. Infect Immun 2004; 72: 5470-5474.
87. Hess S, Rheinheimer C, Tidow F, et al. The reprogrammed host: Chlamydia trachomads-induced up-regulation of glycoprotein 130 cytokines, transcription factors, and antiapoptatic genes. Arthritis Rheum 2001; 44: 2392-2401.
88. Ying S, Seiffert B, Häcker G, Fischer SF. Broad degradation of pro-apoptotic BH3-only proteins during infection with Chlamydia trachomatis. Infect Immun 2005; 73: 1399-1403.
89. Dong F, Pirbhai M, Xiao Y, Zhong Y, Wu Y, Zhong G. Degradation of the proapoptotic proteins Bik, Puma, and Bim with Bcl-2 domain 3 homology in Chlamydia trachomatis-infected cells. Infect Immun 2005; 73: 1861-1864.
90. McDonnell JM, Fushman D, Milliman CL, Korsmeyer SJ, Cowburn D. Solution structure of the proapoptotic molecule BID: a structural basis for apoptotic agonists and antagonists. Cell 1999; 96(5): 625-34.
91. Chen YL, Law PY, Loh HH. Inhibition of P13K/Akt signaling: an emerging paradigm for targeted cancer therapy. Curr Med Chem Anticancer Agents 2005; 5: 575-589.
92. Scidmore MA, Hackstadt T. Mammalian 14-3-3b associates with the Chlamydia trachomatis inclusion membrane via its interaction with IncG. Mol Microbiol 2001; 39:1638-1650.
93. Li, L, Lorenzo PS, Bogi K, Blumberg PM, Yuspa SH. Protein kinase Cdelta targets mitochondria, alters mitochondrial membrane potential, and induces apoptosis in normal and neoplastic ketatinocytes when overexpressed by an adenoviral vector. Mol Cell Biol 1999; 19(12): 8547-8558.
94. Tse SM, Mason D, Botelho RJ, et al. Accumulation of diacylglycerol in the Chlamydia inclusion vacaole: possible role in the inhibition of host cell apoptosis. J Biol Chem 2005; 280: 25210-25215.
95. Ruhland A, Leal N, Kima PE. Leishmania promastigotes activate P13K/ Akt signalling to confer host cell resistance to apoptosis. Cell Microbiol 2006; in press.
96. Yilmaz O, Jungas T, Verbeke P, Ojcius DM. Activation of the phosphatidylinositol 3-kinase/Akt pathway contributes to survival of primary epithelial cells infected with the periodontal pathogen Porphyromonas gingivalis. Infect Immun 2004; 72: 3743-3751.
97. Aoki Mdel P, Cano RC, Pellegrini AV, et al. Different signaling pathways are involved in cardiomyocyte survival induced by a Trypanosoma cruzi glycoprotein. Microbes Infect 2006; 8: 1723-1731.
98. Rajala MS, Rajala RV, Astley RA, Butt AL, Chodosh J. Corneal cell survival in adenovirus type 19 infection requires phosphoinositide 3-kinase/Akt activation. J Virol 2005; 79:12332-12341.
99. Mannova P, Beretta L. Activation of the N-Ras-P13K-Akt-mTOR pathway by hepatitis C virus: control of cell survival and viral replication. J Virol 2005; 79: 8742-8749.
100. Lee CJ, Liao CL, Lin YL. Flavivirus activates phosphatidylinositol 3-kinase signaling to block caspase-dependent apoptotic cell death at the early stage of virus infection. J Virol 2005; 79: 8388-8399.
101. Portis T, Longnecker R, Epstein-Barr virus (EBV) LMP2A mediates B-lymphocyte survival through constitutive activation of the Ras/P13K/ Akt pathway. Oncogene 2004; 23: 8619-8628.
102. Street A, Macdonald A, Crowder K, Harris M. The Hepatitis C virus NS5A protein activates a phosphoinositide 3-kinase-dependent survival signaling cascade. J Biol Chem 2004; 279: 12232-12241.
103. Bonizzi G, Karin M. The two NF-kappaB activation pathways and their role in innate and adaptive immunity. Trends Immunol 2004; 25(6): 280-8.
104. Beg AA, Sha WC, Bronson RT, Ghosh S, Baltimore D. Embryonic lethality and liver degeneration in mice lacking the Re1A component of NF-kappa B. Nature 1995; 376(6536): 167-170.
105. Karin M, Lin A. NF-κB at the crossroads of life and death. Nat Immunol 2002; 3: 221-227.
106. Eckelman BP, Salvesen GS. The human anti-apoptotic proteins cIAP1 and cIAP2 bind but do not inhibit caspases. J Biol Chem 2006; 281: 3254-3260.
107. Wahl C, Oswald F, Simnacher U, Weiss S, Marre R, Essig A. Survival of Chlamydia pneumoniae-infected Mono Mac 6 cells is dependent on NF-kappaB binding activity. Infect Immun 2001; 69: 7039-7045.
108. Krull M, Klucken AC, Wuppermann FN, et al. Signal transduction pathways activated in endothelial cells following infection with Chlamydia pneumoniae. J Immunol 1999; 162: 4834-4841.
109. Xiao Y, Zhong Y, Su H, Zhou Z, Chiao P, Zhong G. NF-kappa B activation is not required for Chlamydia trachomatis inhibition of host epithelial cell apoptosis. J Immunol 2005; 174: 1701-1708.
110. Paland N, Rajalingam K, Machuy N, Szczepek A, Wehrl W, Rudel T. NF-κB and inhibitor of apoptosis proteins are required for apoptosis resistance of epithelial cells persistently infected with Chlamydophila pneumoniae. Cell Microbiol 2006; in press.
111. Pagliari LJ, Perlman H, Liu H, Pope RM. Macrophages require constitutive NF-kappaB activation to maintain A1 expression and mitochondrial homeostasis. Mol Cell Biol 2000; 20: 8855-8865.
112. Perfettini JL, Reed JC, Israel N, Martinou JC, Dautry-Varsat A, Ojcius DM. Role of Bcl-2 family members in caspase-independent apoptosis during Chlamydia infection. Infect Immun 2002; 70: 55-61.
113. Dumrese C, Maurus CF, Gygi D, et al. Chlamydia pneumoniae induces aponecrosis in human aortic smooth muscle cells. BMC Microbiol 2005; 5: 2.
114. Banks J, Eddie B, Schachter J, Meyer KF. Plaque formation by Chlamydia in L cells. Infect Immun 1970; 1: 259-262.
115. Friis RR. Interaction of L cells and Chlamydia psittaci: entry of the parasite and host responses to its development. J Bacteriol 1972; 180: 706-721.
116. Todd WJ, Storz J. Ultrastructurul cytochemical evidence for the activation of lysosomes in the cytocidal effect of Chlamydia psittaci. Infect Immun 1975; 12: 638-646.
117. Wyrick PB, Brownridge EA, Ivins BE. Interaction of Chlamydia psittaci with mouse peritoneal macrophages. Infect Immun 1978; 19: 1061-1067.
118. Chang GT, Moulder JW. Loss of inorganic ions from host cells infected with Chlamydia psittaci. Infect Immun 1978; 19: 827-832.
119. Perfettini JL, Ojcius DM, Andrews CW, Korsmeyer SJ, Rank RG, Darville T. Role of proapoptotic BAX in propagation of Chlamydia muridarum (the mouse pneumonitis strain of Chlamydia trachomatis) and the host inflammatory response. J Biol Chem 2003; 278: 9496-9502.
120. Lupu M, Ojcius D, Perfettini JL, Patry J, Dimicoli JL, Mispelter J. Changes of sodium ion compartmentalization in biological systems due to pathological states. A noninvasive NMR study. Biochimie 2003; 85: 849-861.
121. Scaffidi P, Misteli T, Bianchi ME. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 2002; 418: 191-195.
122. Ojcius DM, Souque P, Perfettini JL, Dautry-Varsat A. Apoptosis of epithelial cells and macrophages due to infection with the obligate intracellular pathogen Chlamydia psittaci. J Immunol 1998; 161: 4220-4226.
123. Zhou G, Roizman B. Wild-type herpes simplex virus 1 blocks programmed cell death and release of cytochrome c but not the translocation of mitochondrial apoptosis-inducing factor to the nuclei of human embryonic lung fibroblasts. J Virol 2000; 74: 9048-9053.
124. Mitchell L, Smith SH, Braun JS, Herzog KH, Weber JR, Tuomanen EI. Dual phases of apoptosis in pneumococcal meningitis. J Infect Dis 2004; 190: 2039-2046.
125. Haslinger-Loffler B, Wagner B, Bruck M, et al. Staphylococcus aureus induces caspase-independent cell death in human peritoneal mesothelial cells. Kidney Int 2006; 70: 1089-1098.
126. Sarmento L, Tseggai T, Dhingra V, Fu ZF. Rabies virus-induced apoptosis involves caspase-dependent and caspase-independent pathways. Virus Res 2006; 121: 144-151.
127. Lee J, Remold HG, Ieong MH, Kornfeld H. Macrophage apoptosis in response to high intracellular burden of Mycobacterium tuberculosis is mediated by a novel caspase-independent pathway. J Immunol 2006; 176: 4267-4274.
128. Weinrauch Y, Zychlinsky A. The induction of apoptosis by bacterial pathogens. Annu Rev Microbiol 1999; 53: 155-187.
129. Abu Kwaik Y, Gao L-Y. The modulation of host cell apoptosis by intracellular bacterial pathogens. Trends Microbiol 2000; 8: 306-313.
130. Hacker G, Kirschnek S, Fischer SF. Apoptosis in infectious disease: how bacteria interfere with the apoptotic apparatus. Med Microbiol Immunol (Berl) 2006; 195: 11-19.
131. McClarty G. Chlamydiae and the biochemistry of intracellular parasitism. Trends Microbiol 1994; 2: 157-164.
132. Beatty PR, Rasmussen SJ, Stephens RS. Cross-reactive cytotoxic T-lymphocyte-mediated lysis of Chlamydia trachomatis- and Chlamydia psittaci-infected cells. Infect Immun 1997; 65: 951-956.
133. + T lymphocyte-mediated lysis of Chlamydia-infected L cells using an endogenous antigen pathway. J Immunol 1994; 153: 4588-4595.
134. + T cell responses in humans. J Immunol 2003; 171: 4278-4286.
135. + CTLs specific for the major outer membrane protein of Chlamydia trachomatis in human genital tract infections. J Immunol 1999; 162: 6855-6866.
136. Popov I, Dela Cruz CS, Barber BH, Chiu B, Inman RD. The effect of an anti-HLA-B27 immune response on CTL recognition of Chlamydia. J Immunol 2001; 167: 3375-3382.
137. Saren A, Pascolo S, Stevanovic S, et al. Identification of Chlamydia pneumoniae-derived mouse CD8 epitopes. Infect Immun 2002; 70: 3336-3343.
138. Starnbach MN, Bevan MJ, Lampe MF. Marine cytotoxic T lymphocytes induced following Chlamydia trachomatis intraperitoneal or genital tract infection respond to cells infected with multiple serovars. Infect Immun 1995; 63: 3527-3530.
139. + Tc1 responses that inhibit intracellular growth of this vacuolar pathogen. J Immunol 2002; 169: 2524-2535.
140. Henson PM, Bratton DL, Fadok VA. Apoptatic cell removal. Curr Biol 2001; 11: R795-R805.
141. Fadok VA, Henson PM. Apoptosis: giving phosphatidylserine recognition an assist - with a twist. Curr Biol 2003; 13: R655-R657.
142. van Zandbergen G, Gieffers J, Kothe H, et al. Chlamydia pneumoniae multiply in neutrophil granulocytes and delay their spontaneous apoptosis. J Immunol 2004; 172: 1768.
143. Monks J, Rosner D, Jon Geske F, et al. Epithelial cells as phagocytes: apoptotic epithelial cells are engulfed by mammary alveolar epithelial cells and repress inflammatory mediator release. Cell Death Diff 2005; 12: 107.
144. Winau F, Weber S, Sad S, et al. Apoptotic vesicles crossprime CD8 T cells and protect against tuberculosis. Immunity 2006; 24: 105-117.
145. Huynh M-LN, Fadok VA, Henson PM. Phosphatidylserine-dependent ingestion of apoptotic cells promotes TGF-β1 secretion and the resolution of inflammation. J Clin Invest 2002; 109: 41-50.
146. Fadok VA, Bratton DL, Konowal A, Freed PW, Westcott JY, Henson PM. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-β, PGE2, and PAF. J Clin Invest 1998; 101: 890-898.
147. Rottenberg ME, Gigliotti Rothfuchs AC, Gigliotti D, Svanholm C, Bandholtz L, Wigzell H. Role of innate and adaptive immunity in the outcome of primary infection with Chlamydia pneumoniae, as analyzed in genetically modified mice. J Immunol 1999; 162: 2829-2836.
148. Bachmaier K, Penninger JM. Chlamydia and antigenic mimicry. Curr Top Microbiol Immunol, 2005; 296: 153-163.
149. + T cell heptaepitope minigene vaccine induces protective immunity against Chlamydia pneumoniae. J Immunol 2005; 174: 5729-5739.
150. + T cells recognize the 60-kDa cysteine-rich outer membrane protein from Chlamydia trachomatis. J Immunol 2004; 173: 6905-6913.
151. + T cell response. J Immunol 2003; 171: 4742-4749.
152. Williams DM, Grubbs BG, Pack E, Kelly KA, Rank RG. Humoral and cellular immunity in secondary infection due to murine Chlamydia trachomatis. Infect Immun 1997; 65: 2876-2882.
153. Lich JD, Arthur JC, Ting JP-Y. Cryopyrin: in from the cold. Immunity 2006; 24: 241-243.
154. Mariathasan, S, Weiss DS, Newton K, et al. Cryopyrin activates the inflammasome in response to toxins and ATP. Nature 2006; 440: 228-232.
155. Meylan E, Tschopp J, Karin M. Intracellular pattern recognition receptors in the host response. Nature 2006; 442: 39-44.
156. Ojcius DM, Bravo de Alba Y, Kanellopoulos JM, et al. Internalization of Chlamydia by dendritic cells and stimulation of Chlamydia-specific T cells. J Immunol 1998; 160: 1297-1303.
157. Matyszak MK, Young JL, Gaston JS. Uptake and processing of Chlamydia trachomatis by human dendritic cells. Eur J Immunol 2002; 32: 742-751.
158. Bertho N, Adamski H, Toujas I, Debove M, Davoust J, Quillien V. Efficient migration of dendritic cells toward lymph node chemokines and induction of T(H)1 responses require maturation stimulus and apoptotic cell interaction. Blood 2005; 106: 1734-1741.